Events Press Releases Investor Home Investor Resources Corporate Presentation> Stock Information> SEC Filings> Analyst Coverage> Investor FAQ> Corporate Governance> Committee> IR Home> Topline Results from Paltusotine Phase 3 PATHFNDR-2 Study Mar 19, 2024 at 8:30 AM EDT Live and Archive Webcast Supporting Materials PF2 Ph3 Investor Deck 3 18 24_Webcast FINAL.pdf 879.3 KB Email Alerts RSS Feeds Print Email Page Events Press Releases Investor Home Contact Press Releases & Events> Financial Alerts> Media Inquiries> Contact IR> Required fields denoted by an asterisk (). Alert type Quote SEC Filing Weekly Summary Email Leave this field blank First Name Last Name Email Organization Message Leave this field blank Contact Press Releases & Events> Financial Alerts> Required fields denoted by an asterisk (). Alert type Quote SEC Filing Weekly Summary Email Leave this field blank Media Inquiries> Contact IR> First Name Last Name Email Organization Message Leave this field blank
Topline Results from Paltusotine Phase 3 PATHFNDR-2 Study Mar 19, 2024 at 8:30 AM EDT Live and Archive Webcast Supporting Materials PF2 Ph3 Investor Deck 3 18 24_Webcast FINAL.pdf 879.3 KB